A. August

发表

A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age.

G. Glenn, L. Fries, D. N. Thomas, 2017, Vaccine.

Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial

D. Montefiori, J. Tomassini, S. Swaminathan, 2022, The Journal of infectious diseases.

Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: a phase III, randomized, multicentre, lot-to-lot consistency study.

J. McVernon, H. Marshall, D. Toneatto, 2015, Vaccine.

Cytomegalovirus infection in day-care center.

R. Pass, A. August, D. Reynolds, 1982, The New England journal of medicine.

Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants.

M. Lucero, S. Madhi, H. Zar, 2020, The New England journal of medicine.

T lymphocyte subpopulations in congenital cytomegalovirus infection

R. Pass, A. August, M. Roper, 1983, Infection and immunity.

Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.

N. Patel, G. Glenn, L. Fries, 2019, The Journal of infectious diseases.

Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults

T. Zaks, C. Shaw, I. Smolenov, 2022, Open forum infectious diseases.

Malaria vaccine trials in pregnant women: An imperative without precedent.

S. Hoffman, O. Doumbo, C. Menéndez, 2019, Vaccine.

A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus

J. Lecerf, J. Crowe, L. Ptaszek, 2021, Nature Medicine.

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

J. Mascola, C. Fichtenbaum, D. Follmann, 2021, The New England journal of medicine.

Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy

R. Whitley, C. Alford, S. Stagno, 1981, Infection and immunity.

Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge

J. Tomassini, K. Neuzil, B. Girard, 2021, medRxiv.

Vaccination of pregnant women with respiratory syncytial virus vaccine and protection of their infants

M. Lucero, S. Madhi, H. Zar, 2020, The New England journal of medicine.

Antibody response to cytomegalovirus after renal transplantation: comparison of patients with primary and recurrent infections.

P. Griffiths, R. Pass, A. August, 1983, The Journal of infectious diseases.

Vaccination of pregnant women with respiratory syncytial virus vaccine and protection of their infants.

M. Lucero, S. Madhi, H. Zar, 2020, The New England journal of medicine.

Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge

D. Follmann, J. Tomassini, K. Neuzil, 2021, The New England journal of medicine.

234. Safety and Immunogenicity of mRNA-1345, an mRNA-Based RSV Vaccine in Younger and Older Adult Cohorts: Results from a Phase 1, Randomized Clinical Trial

S. Stoszek, C. Shaw, Grace L. Chen, 2022, Open Forum Infectious Diseases.

A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults.

S. Weaver, C. Shaw, T. Brasel, 2023, Vaccine.

Ethics, pregnancy, and ZIKV vaccine research & development Ethics Working Group on ZIKV Research and Pregnancy

R. Karron, A. Lyerly, N. Kass, 2021 .

Ethics, pregnancy, and ZIKV vaccine research & development.

R. Karron, A. Lyerly, C. Krubiner, 2017, Vaccine.

A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age.

G. Glenn, L. Fries, D. N. Thomas, 2017, Vaccine.